Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
Cytogen Corporation and Dowpharma collaborate to create a targeted oncology product designed to treat prostate and other cancers

Cytogen Corporation and Dowpharma collaborate to create a targeted oncology product designed to treat prostate and other cancers

Scientists use tobacco plants to create antibodies against tumor cells

Scientists use tobacco plants to create antibodies against tumor cells

Promising new West Nile therapy cures disease in mice

Promising new West Nile therapy cures disease in mice

New breast cancer drug combo could save thousands of lives

New breast cancer drug combo could save thousands of lives

Australian researchers develop West Nile virus treatment

Australian researchers develop West Nile virus treatment

Search for new multiple sclerosis drug

Search for new multiple sclerosis drug

Antibody for West Nile virus shows promise

Antibody for West Nile virus shows promise

Increased scrutiny of new multiple sclerosis-fighting drugs after Tysabri withdrawal

Increased scrutiny of new multiple sclerosis-fighting drugs after Tysabri withdrawal

Researchers have identified a new clinical syndrome

Researchers have identified a new clinical syndrome

Tarvacin shows significant anti-viral activity

Tarvacin shows significant anti-viral activity

Herceptin - more powerful treatment for patients with HER-2-positive breast cancer

Herceptin - more powerful treatment for patients with HER-2-positive breast cancer

Drug combo gives lung cancer patients longer life

Drug combo gives lung cancer patients longer life

Bevacizumab (Avastin) in combination with standard chemotherapy helps advanced lung cancer sufferers

Bevacizumab (Avastin) in combination with standard chemotherapy helps advanced lung cancer sufferers

Investigational drug may help prevent recurrence of ovarian cancer

Investigational drug may help prevent recurrence of ovarian cancer

Monoclonal antibody therapeutics to fill vacuum left by ineffective conventional therapies

Monoclonal antibody therapeutics to fill vacuum left by ineffective conventional therapies

Novel vaccine that uses immune cells as factories to produce Her2/neu protein may offer a way to treat some breast cancers

Novel vaccine that uses immune cells as factories to produce Her2/neu protein may offer a way to treat some breast cancers

Why the Mediterranean diet appers to protect against breast cancer

Why the Mediterranean diet appers to protect against breast cancer

New technique could lead to more effective therapies for AIDS

New technique could lead to more effective therapies for AIDS

GlaxoSmithKline acquires full marketing and development rights for BEXXAR worldwide

GlaxoSmithKline acquires full marketing and development rights for BEXXAR worldwide

Alliance to develop and commercialize fully-human anti-anthrax antibody

Alliance to develop and commercialize fully-human anti-anthrax antibody